Microphysiological Engineering of Immune Responses in Intestinal Inflammation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The epithelial barrier in the gastrointestinal (GI) tract is a protective interface that endures constant exposure to the external environment while maintaining its close contact with the local immune system. Growing evidence has suggested that the intercellular crosstalk in the GI tract contributes to maintaining the homeostasis in coordination with the intestinal microbiome as well as the tissue-specific local immune elements. Thus, it is critical to map the complex crosstalks in the intestinal epithelial-microbiome-immune (EMI) axis to identify a pathological trigger in the development of intestinal inflammation, including inflammatory bowel disease. However, deciphering a specific contributor to the onset of pathophysiological cascades has been considerably hindered by the challenges in current in vivo and in vitro models. Here, we introduce various microphysiological engineering models of human immune responses in the EMI axis under the healthy conditions and gut inflammation. As a prospective model, we highlight how the human “gut inflammation-on-a-chip” can reconstitute the pathophysiological immune responses and contribute to understanding the independent role of inflammatory factors in the EMI axis on the initiation of immune responses under barrier dysfunction. We envision that the microengineered immune models can be useful to build a customizable patient's chip for the advance in precision medicine.
Abstract
The epithelial barrier in the gastrointestinal (GI) tract is a protective interface that endures constant exposure to the external environment while maintaining its close contact with the local immune system. Growing evidence has suggested that the intercellular crosstalk in the GI tract contributes to maintaining the homeostasis in coordination with the intestinal microbiome as well as the tissue-specific local immune elements. Thus, it is critical to map the complex crosstalks in the intestinal epithelial-microbiome-immune (EMI) axis to identify a pathological trigger in the development of intestinal inflammation, including inflammatory bowel disease. However, deciphering a specific contributor to the onset of pathophysiological cascades has been considerably hindered by the challenges in current in vivo and in vitro models. Here, we introduce various microphysiological engineering models of human immune responses in the EMI axis under the healthy conditions and gut inflammation. As a prospective model, we highlight how the human “gut inflammation-on-a-chip” can reconstitute the pathophysiological immune responses and contribute to understanding the independent role of inflammatory factors in the EMI axis on the initiation of immune responses under barrier dysfunction. We envision that the microengineered immune models can be useful to build a customizable patient's chip for the advance in precision medicine.
참고문헌 (88)
- Lazar V, "Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer", Front Immunol, 9, pp.1830~ (2018)
- Magro DO, "Remission in Crohn's disease is accompanied by alterations in the gut microbiota and mucins production", Sci Rep, 9, pp.13263~ (2019)
- Castaner O, "The gut microbiome profile in obesity : a systematic review", Int J Endocrinol, 2018, pp.1~9 (2018)
- Basson AR, "Complementary and alternative medicine strategies for therapeutic gut microbiota modulation in inflammatory bowel disease and their next-generation approaches", Gastroenterol Clin North Am, 46, pp.689~729 (2017)
- Javanmard A, "Probiotics and their role in gastrointestinal cancers prevention and treatment; an overview", Gastroenterol Hepatol Bed Bench, 11, pp.284~295 (2018)
- Bruno G, "Fecal Microbial Transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent Clostridium difficile infection patients", New Microbiol, 42, pp.221~224 (2019)
- Vaughn BP, "Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn's disease", Inflamm Bowel Dis, 22, pp.2182~2190 (2016)
- Young VB, "The intestinal microbiota in health and disease", Curr Opin Gastroenterol, 28, pp.63~69 (2012)
- Walker AW, "Phylogeny, culturing, and metagenomics of the human gut microbiota", Trends Microbiol, 22, pp.267~274 (2014)
- Park GS, "Emulating host-microbiome ecosystem of human gastrointestinal tract in vitro", Stem Cell Rev Rep, 13, pp.321~334 (2017)
- Nguyen TL, "How informative is the mouse for human gut microbiota research", Dis Model Mech, 8, pp.1~16 (2015)
- Kim HJ, "Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip", Proc Natl Acad Sci U S A, 113, pp.E7~ (2016)
- Shin W, "Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip", Proc Natl Acad Sci U S A, 115, pp.E10539~ (2018)
- Maurer M, "A three-dimensional immunocompetent intestine-on-chip model as in vitro platform for functional and microbial interaction studies", Biomaterials, 220, pp.119396~ (2019)
- Ramadan Q, "NutriChip : nutrition analysis meets microfluidics", Lab Chip, 13, pp.196~203 (2013)
- Yissachar N, "An Intestinal organ culture system uncovers a role for the nervous system in microbe-immune crosstalk", Cell, 168, pp.1135~1148 (2017)
- Belkaid Y, "Role of the microbiota in immunity and inflammation", Cell, 157, pp.121~141 (2014)
- Wu HJ, "The role of gut microbiota in immune homeostasis and autoimmunity", Gut Microbes, 3, pp.4~14 (2012)
- Bose M, "Role of microbiome in modulating immune responses in cancer", Mediators Inflamm, 2019, pp.4107917~ (2019)
- van der Flier LG, "Stem cells, self-renewal, and differentiation in the intestinal epithelium", Annu Rev Physiol, 71, pp.241~260 (2009)
- Schneider C, "Regulation of immune responses by tuft cells", Nat Rev Immunol, 19, pp.584~593 (2019)
- Dillon A, "M cells : intelligent engineering of mucosal immune surveillance", Front Immunol, 10, pp.1499~ (2019)
- Sambuy Y, "The Caco-2 cell line as a model of the intestinal barrier : influence of cell and culture-related factors on Caco-2 cell functional characteristics", Cell Biol Toxicol, 21, pp.1~26 (2005)
- Phillips TE, "Human intestinal goblet cells in monolayer culture : characterization of a mucus-secreting subclone derived from the HT29 colon adenocarcinoma cell line", Gastroenterology, 94, pp.1390~1403 (1988)
- 이성희, "Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases", Intestinal research, 13(1), pp.11~18 (2015), 대한장연구학회[DOI]
- Lewis JE, "E-cadherin mediates adherens junction organization through protein kinase C", J Cell Sci, 107, pp.3615~3621 (1994)
- Johansson ME, "The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions", Proc Natl Acad Sci U S A, 108(Suppl 1), pp.4659~4665 (2011)
- Scherer WF, "Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells(strain HeLa)derived from an epidermoid carcinoma of the cervix", J Exp Med, 97, pp.695~710 (1953)
- Weng XH, "Cultured monolayers of the dog jejunum with the structural and functional properties resembling the normal epithelium", Am J Physiol Gastrointest Liver Physiol, 288, pp.G705~ (2005)
- Gillet JP, "The clinical relevance of cancer cell lines", J Natl Cancer Inst, 105, pp.452~458 (2013)
- Kasendra M, "Duodenum intestine-chip for preclinical drug assessment in a human relevant model", Elife, 9, pp.e50135~ (2020)
- Wang Y, "In vitro generation of colonic epithelium from primary cells guided by microstructures", Lab Chip, 14, pp.1622~1631 (2014)
- Sato T, "Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche", Nature, 459, pp.262~265 (2009)
- Williamson IA, "A high-throughput organoid microinjection platform to study gastrointestinal microbiota and luminal physiology", Cell Mol Gastroenterol Hepatol, 6, pp.301~319 (2018)
- Kelsall BL, "Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease", Immunol Rev, 206, pp.132~148 (2005)
- Stephen-Victor E, "Regulation of oral immune tolerance by the microbiome in food allergy", Curr Opin Immunol, 60, pp.141~147 (2019)
- Alpan O, "Oral tolerance and gut-oriented immune response to dietary proteins", Curr Allergy Asthma Rep, 1, pp.572~577 (2001)
- Mabbott NA, "Microfold(M)cells : important immunosurveillance posts in the intestinal epithelium", Mucosal Immunol, 6, pp.666~677 (2013)
- Jung C, "Peyer's patches : the immune sensors of the intestine", Int J Inflamm, 2010, pp.823710~ (2010)
- Van Kaer L, "Development, homeostasis, and functions of intestinal intraepithelial lymphocytes", J Immunol, 200, pp.2235~2244 (2018)
- Geremia A, "Innate lymphoid cells in intestinal inflammation", Front Immunol, 8, pp.1296~ (2017)
- Sujino T, "Tissue adaptation of regulatory and intraepithelial CD4+ T cells controls gut inflammation", Science, 352, pp.1581~1586 (2016)
- Stagg AJ, "Intestinal dendritic cells in health and gut inflammation", Front Immunol, 9, pp.2883~ (2018)
- Bain CC, "Origin, differentiation, and function of intestinal macrophages", Front Immunol, 9, pp.2733~ (2018)
- Chen Y, "Targeted delivery of antigen to intestinal dendritic cells induces oral tolerance and prevents autoimmune diabetes in NOD mice", Diabetologia, 61, pp.1384~1396 (2018)
- Regner EH, "Functional intraepithelial lymphocyte changes in inflammatory bowel disease and spondyloarthritis have disease specific correlations with intestinal microbiota", Arthritis Res Ther, 20, pp.149~ (2018)
- Mowat AM, "Regional specialization within the intestinal immune system", Nat Rev Immunol, 14, pp.667~685 (2014)
- Brandtzaeg P, "Function of mucosa-associated lymphoid tissue in antibody formation", Immunol Invest, 39, pp.303~355 (2010)
- den Besten G, "The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism", J Lipid Res, 54, pp.2325~2340 (2013)
- d'Hennezel E, "Total lipopolysaccharide from the human gut microbiome silences toll-like receptor signaling", mSystems, 2, pp.e00046~ (2017)
- Porter NT, "The critical roles of polysaccharides in gut microbial ecology and physiology", Annu Rev Microbiol, 71, pp.349~369 (2017)
- Parada Venegas D, "Short chain fatty acids(SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases", Front Immunol, 10, pp.277~ (2019)
- Brehm CU, "Inulin, the gut microbiome and the deeper breath of asthma patients-novel pathways in asthma treatment", EBioMedicine, 46, pp.15~16 (2019)
- Mao B, "Effects of different doses of fructooligosaccharides(FOS)on the composition of mice fecal microbiota, especially the bifidobacterium composition", Nutrients, 10, pp.1105~ (2018)
- Cheng W, "Effects of a galacto-oligosaccharide-rich diet on fecal microbiota and metabolite profiles in mice", Food Funct, 9, pp.1612~1620 (2018)
- Wong JM, "Colonic health : fermentation and short chain fatty acids", J Clin Gastroenterol, 40, pp.235~243 (2006)
- Okumura R, "Maintenance of intestinal homeostasis by mucosal barriers", Inflamm Regen, 38, pp.5~ (2018)
- Walsh CJ, "Beneficial modulation of the gut microbiota", FEBS Lett, 588, pp.4120~4130 (2014)
- Espey MG, "Role of oxygen gradients in shaping redox relationships between the human intestine and its microbiota", Free Radic Biol Med, 55, pp.130~140 (2013)
- Shin W, "A robust longitudinal co-culture of obligate anaerobic gut microbiome with human intestinal epithelium in an anoxic-oxic interface-on-a-chip", Front Bioeng Biotechnol, 7, pp.13~ (2019)
- Ingber DE, "Reverse engineering human pathophysiology with organs-on-chips", Cell, 164, pp.1105~1109 (2016)
- Lock JY, "Mucus models to evaluate the diffusion of drugs and particles", Adv Drug Deliv Rev, 124, pp.34~49 (2018)
- Hansson GC, "Role of mucus layers in gut infection and inflammation", Curr Opin Microbiol, 15, pp.57~62 (2012)
- Worthington JJ, "Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity", Mucosal Immunol, 11, pp.3~20 (2018)
- Shin W, "Pathomimetic modeling of human intestinal diseases and underlying host-gut microbiome interactions in a gut-on-a-chip", Methods Cell Biol, 146, pp.135~148 (2018)
- Kim HJ, "Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow", Lab Chip, 12, pp.2165~2174 (2012)
- Basson MD, "Schlafen 12 interaction with SerpinB12 and deubiquitylases drives human enterocyte differentiation", Cell Physiol Biochem, 48, pp.1274~1290 (2018)
- Kim HJ, "Gut-on-a-chip microenvironment induces human intestinal cells to undergo villus differentiation", Integr Biol, 5, pp.1130~1140 (2013)
- Bein A, "Microfluidic organ-on-a-chip models of human intestine", Cell Mol Gastroenterol Hepatol, 5, pp.659~668 (2018)
- Jalili-Firoozinezhad S, "A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip", Nat Biomed Eng, 3, pp.520~531 (2019)
- Shah P, "A microfluidics-based in vitro model of the gastrointestinal human-microbe interface", Nat Commun, 7, pp.11535~ (2016)
- Shin W, "Human intestinal morphogenesis controlled by transepithelial morphogen gradient and flow-dependent physical cues in a microengineered gut-on-a-chip", iScience, 15, pp.391~406 (2019)
- Kinchen J, "Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease", Cell, 175, pp.372~386 (2018)
- Grosberg A, "Ensembles of engineered cardiac tissues for physiological and pharmacological study : heart on a chip", Lab Chip, 11, pp.4165~4173 (2011)
- Ma LD, "Design and fabrication of a liver-on-a-chip platform for convenient, highly efficient, and safe in situ perfusion culture of 3D hepatic spheroids", Lab Chip, 18, pp.2547~2562 (2018)
- Bovard D, "A lung", liver-on-a-chip platform for acute and chronic toxicity studies, 2018, pp.18, 3814~3829
- Jang KJ, "Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment", Integr Biol, 5, pp.1119~1129 (2013)
- Wilson SS, "A small intestinal organoid model of non-invasive enteric pathogen-epithelial cell interactions", Mucosal Immunol, 8, pp.352~361 (2015)
- Wang S, "The dynamic roles of mesenchymal stem cells in colon cancer", Can J Gastroenterol Hepatol, 2018, pp.7628763~ (2018)
- Sunuwar L, "Mechanical stimuli affect Escherichia coli heat-stable enterotoxin-cyclic GMP signaling in a human enteroid intestine-chip model", Infect Immun, 88, pp.e00866~ (2019)
- Finkbeiner SR, "Stem cell-derived human intestinal organoids as an infection model for rotaviruses", MBio, 3, pp.e00159~ (2012)
- Shum E, "PD-L1 expression profile and immunotherapy(IO)experience in African American(AA)and Hispanic(H)lung cancer(LC)patients : Addressing disparities at a minority-based academic cancer center", J Clin Oncol, 35(15_suppl), pp.e18073~ (2017)
- Sontheimer-Phelps A, "Human colon-on-a-chip enables continuous in vitro analysis of colon mucus layer accumulation and physiology", Cell Mol Gastroenterol Hepatol, 9, pp.507~526 (2019)
- Packey CD, "Molecular detection of bacterial contamination in gnotobiotic rodent units", Gut Microbes, 4, pp.361~370 (2013)
- Bernareggi D, "Development of innate immune cells from human pluripotent stem cells", Exp Hematol, 71, pp.13~23 (2019)
- Barbazan J, "Prognostic impact of modulators of G proteins in circulating tumor cells from patients with metastatic colorectal cancer", Sci Rep, 6, pp.22112~ (2016)
- Reimers N, "Liquid biopsy : novel technologies and clinical applications", Clin Chem Lab Med, 57, pp.312~316 (2019)
- Wagar LE, "Advanced model systems and tools for basic and translational human immunology", Genome Med, 10, pp.73~ (2018)
